Gene · 406932
Papers3,316
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,316
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Differential Expression Analysis Based on Ensemble Strategy on miRNA Profiles of Kidney Clear Cell Carcinoma. | Front Biosci (Landmark Ed) | 2023 | 38062803 | PubTator, text mining | PubMed |
| Non-coding RNAs expression in SARS-CoV-2 infection: pathogenesis, clinical significance, and therapeutic targets. | Signal Transduct Target Ther | 2023 | 38057315 | PubTator, text mining | PubMed |
| Advancements in engineered exosomes for wound repair: current research and future perspectives. | Front Bioeng Biotechnol | 2023 | 38033824 | PubTator, text mining | PubMed |
| Downregulated M6A modification and expression of circRNA_103239 promoted the progression of glioma by regulating the miR-182-5p/MTSS1 signalling pathway. | J Cancer | 2023 | 38021156 | PubTator, text mining | PubMed |
| The Emerging Roles of Exosomal miRNAs in Breast Cancer Progression and Potential Clinical Applications. | Breast Cancer (Dove Med Press) | 2023 | 38020052 | PubTator, text mining | PubMed |
| Nanoparticles and Mesenchymal Stem Cell (MSC) Therapy for Cancer Treatment: Focus on Nanocarriers and a si-RNA CXCR4 Chemokine Blocker as Strategies for Tumor Eradication In Vitro and In Vivo. | Micromachines (Basel) | 2023 | 38004925 | PubTator, text mining | PubMed |
| Plant-Derived Epi-Nutraceuticals as Potential Broad-Spectrum Anti-Viral Agents. | Nutrients | 2023 | 38004113 | PubTator, text mining | PubMed |
| Inflammatory and Metabolic Signaling Interfaces of the Hypertrophic and Senescent Chondrocyte Phenotypes Associated with Osteoarthritis. | Int J Mol Sci | 2023 | 38003658 | PubTator, text mining | PubMed |
| MicroRNAs as Molecular Biomarkers for the Characterization of Basal-like Breast Tumor Subtype. | Biomedicines | 2023 | 38002007 | PubTator, text mining | PubMed |
| Differential Expression of MicroRNA (MiR-27, MiR-145) among Dental Pulp Stem Cells (DPSCs) Following Neurogenic Differentiation Stimuli. | Biomedicines | 2023 | 38002003 | PubTator, text mining | PubMed |
| [Research Advances of RAD51AP1 in Tumor Progression and Drug Resistance]. | Zhongguo Fei Ai Za Zhi | 2023 | 37985156 | PubTator, text mining | PubMed |
| Insights into the radiotherapy-induced deferentially expressed RNAs in colorectal cancer management. | Iran J Basic Med Sci | 2023 | 37970448 | PubTator, text mining | PubMed |
| Transmembrane serine protease 2, a SARS-CoV-2 internalization protease, correlates with clinical outcome, molecular features, and immunotherapy response in colorectal cancer. | J Gastrointest Oncol | 2023 | 37969833 | PubTator, text mining | PubMed |
| Fgf2 and Ptpn11 play a role in cerebral injury caused by sevoflurane anesthesia. | Medicine (Baltimore) | 2023 | 37960778 | PubTator, text mining | PubMed |
| Biological and clinical significance of the glypican-3 gene in human lung adenocarcinoma: An in silico analysis. | Medicine (Baltimore) | 2023 | 37960765 | PubTator, text mining | PubMed |
| Bioadhesive and Injectable Hydrogels and Their Correlation with Mesenchymal Stem Cells Differentiation for Cartilage Repair: A Mini-Review. | Polymers (Basel) | 2023 | 37959908 | PubTator, text mining | PubMed |
| Unraveling the Potential of miRNAs from CSCs as an Emerging Clinical Tool for Breast Cancer Diagnosis and Prognosis. | Int J Mol Sci | 2023 | 37958993 | PubTator, text mining | PubMed |
| Circular RNA ZNF800 (hsa_circ_0082096) regulates cancer stem cell properties and tumor growth in colorectal cancer. | BMC Cancer | 2023 | 37950151 | PubTator, text mining | PubMed |
| Network analysis identifies circulating miR-155 as predictive biomarker of type 2 diabetes mellitus development in obese patients: a pilot study. | Sci Rep | 2023 | 37945677 | PubTator, text mining | PubMed |
| Collagen-Based Hydrogels for Cartilage Regeneration. | Orthop Surg | 2023 | 37942509 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406932/papers?page=7